Options include increasing the semaglutide dose, switching to tirzepatide (which engages an additional receptor pathway), or adding a synergistic agent like naltrexone
Overall, we can see the value of targeting the GSH system in myocardial injury
Medicare and Medicaid generally exclude weight loss medications by federal regulation, though some state Medicaid programs have begun making exceptions
Current evidence is insufficient to establish their safety profile in pregnant women, and animal studies have raised concerns about potential developmental risks
Most people move up to 5 mg and, depending on their progress, might eventually increase to 10 mg or more
8 Likes hdeuskar August 18, 2025, 12:47pm 7 And so, it begins Food Chained: How weight-loss drugs are changing Indias eating habits and forcing restaurants to take note - The Economic Times abhay.jain August 18, 2025, 2:19pm 8 I spent the past weeks researching GLP-1 drugs and companies that might benefit from these drugs, what follows is my notes on the topic - disclaimer - i am not a doctor
